Sam Craft

Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

Tom P. Freeman, Chandni Hindocha, Gianluca Baio et al. · The Lancet Psychiatry · 2020 · 192 citations · Full text

Adaptive Bayesian Trial, Cannabis Use, Psychoactive Drug +14

Immunization with AgTRIO, a Protein in Anopheles Saliva, Contributes to Protection against Plasmodium Infection in Mice

Srdjan M. Dragovic, Tolulope A. Agunbiade, Marianna Freudzon et al. · Cell Host & Microbe · 2018 · 57 citations · Full text

Anopheles Saliva, Malaria, Immunology +9

Characterising heterogeneity in the use of different cannabis products: latent class analysis with 55 000 people who use cannabis and associations with severity of cannabis dependence

Sam Craft, Adam Winstock, Jason Ferris et al. · Psychological Medicine · 2019 · 46 citations · Full text

Synthetic cannabinoid use in an adult male prison in the UK

Sam Craft, A. Everett Austin, Tom Tooth et al. · International Journal of Drug Policy · 2023 · 18 citations · Full text

A latent class analysis of cannabis use products in a general population sample of adolescents and their association with paranoia, hallucinations, cognitive disorganisation and grandiosity

Clare Mackie, Jack Wilson, Tom P. Freeman et al. · Addictive Behaviors · 2021 · 17 citations · Full text

Cannabis Use, Substance Abuse, Psychoactive Drug +12